The expansion of Medicaid may drastically change the demographics of beneficiaries.
The expansion of Medicaid may drastically change the demographics of beneficiaries. With health reform, adults making up to 138% of the federal poverty level will be able to sign up for Medicaid under a federally paid expansion starting in 2014. This shift in regulations may result in a more diverse Medicaid population.
According to the recent study, which used statistics from the National Health and Nutrition Examination Survey, the new group of Medicaid beneficiaries are:
Study author Dr Tammy Chang says while the new Medicaid enrollees will be healthier and less obese or depressed than the current population, there will also more will be smokers and drinkers. She adds that the Medicaid population is usually stereotyped as high-risk and chronically ill—this can affect the way doctors and providers view treatment for these beneficiaries since the costs of those patients is often higher.
“It’s really a game changer,” said Dr Chang, “A lot of providers think of Medicaid as people who take a lot of time to see, who use a lot of resources.”
A shift in beneficiary demographics could also mean a greater focus on prevention and family care, rather than chronic disease. Sara Rosenbaum, a health law professor at the George Washington University School of Public Health, says the new information could give hesitant states the incentive they need to pursue Medicaid expansion. “It’s about the need for good family care, routine care,” she said. “One would hope that encourages states to open up their programs.”
Around the Web
How Expansion Will Change The Look Of Medicaid [NPR]
Law Will Shift Demographics For Medicaid Toward Healthier Group, Study Finds [Kaiser Health News]
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
Decitabine, Venetoclax Combo Boosts Survival in Patients With AML and MDS
May 16th 2024Study findings demonstrate that combining decitabine with venetoclax enhances molecular response rates in patients with acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS), correlating strongly with improved clinical outcomes and overall survival.
Read More